LAWSUITS NEWS & LEGAL INFORMATION
AZ Reaches $20M Settlement in Nexium Class Action Lawsuit
Boston,MA: A proposed settlement has been reached with AstraZeneca Pharmaceuticals LP ("AstraZeneca"), the maker of Nexium®, in a consumer fraud class action lawsuit pending in Suffolk County Superior Court in the Commonwealth of Massachusetts ("Lawsuit") : Commonwealth Care Alliance, et al. vs. AstraZeneca Pharmaceuticals L.P., et al., Case No. 05-0269 BLS.
The Lawsuit claims that AstraZeneca deceptively marketed Nexium®. AstraZeneca denies any wrongdoing and has consistently maintained that Nexium® is supported by strong clinical studies, and that the promotion of Nexium® has always been truthful, balanced, and fair.
Although the Court has not ruled on the merits of the Plaintiffs' claims, the parties have agreed to settle this Lawsuit. Based on Class Counsel' extensive investigation of the facts and the law relevant to the Lawsuit, the Plaintiffs and Class Counsel have concluded that the settlement with AstraZeneca is in the best interests of the settlement Class. The proposed Settlement is not an admission of wrongdoing or an indication that any law was violated.
AstraZeneca will pay $20 million to settle the Plaintiffs' claims in the Settlement. After deducting certain amounts, including amounts approved by the Court for the settlement notice and claims administration, payment of attorneys' fees, reimbursement of Plaintiffs' litigation expenses, and service awards to settlement Class Representatives, the net fund will be distributed in cash to settlement Class members who submit valid claims. If Class members' claims exceed the amount available, payments will be reduced on a proportional basis so that all valid claims can be paid. If there is any money left after paying all valid claims, the excess funds will be distributed as cy pres payments to charities agreed to by the parties and approved by the Court.
Generally, you are a member of the settlement Class if you are a person or entity who, during the period from March 1, 2001, through February 6, 2013: (a) purchased Nexium® in or from Massachusetts, or (b) reimbursed or paid for Nexium® dispensed in Massachusetts, or (c) reimbursed or paid for Nexium® purchased by mail order from Massachusetts.
You are not a member of the settlement Class if you are a government entity (except for government-funded employee benefit funds), you purchased Nexium® for purposes of resale (but solely to the extent of such purchases for purposes of resale), or you are the Judge assigned to this action and any member of the Judge' immediate family.
The settlement Class includes both consumers and entities, known as "Third-Party Payors,"that purchased, reimbursed, or paid for Nexium®.
To qualify for payment from the Settlement, you must timely submit a completed Claim Form. Claim Forms must be postmarked, faxed, sent electronically in PDF format, or submitted online by August 30, 2013.
If you have comments about, or objections to, any aspect of the Settlement, including the requested attorneys' fees or service awards, you may express your views to the Court. Refer to the Full Notice for more information on how to express your views to the Court.
If you do nothing, you will not receive a payment from the Settlement, and you won't be able to start a lawsuit, continue with a lawsuit, or be part of any other lawsuit against AstraZeneca about the legal issues in the Lawsuit.
The Court will hold a Fairness Hearing in Boston, Massachusetts on July 13, 2013. The hearing may be moved to a different date or time, so check this website for updated information.
The Fairness Hearing will determine whether or not the Settlement and the plan for distributing it are fair, adequate, and reasonable, among other things. For complete information on the proposed settlement, to download forms and note important dates and contact information, visit: http://www.massachusettsnexiumlitigation.com
Published on Apr-4-13
The Lawsuit claims that AstraZeneca deceptively marketed Nexium®. AstraZeneca denies any wrongdoing and has consistently maintained that Nexium® is supported by strong clinical studies, and that the promotion of Nexium® has always been truthful, balanced, and fair.
Although the Court has not ruled on the merits of the Plaintiffs' claims, the parties have agreed to settle this Lawsuit. Based on Class Counsel' extensive investigation of the facts and the law relevant to the Lawsuit, the Plaintiffs and Class Counsel have concluded that the settlement with AstraZeneca is in the best interests of the settlement Class. The proposed Settlement is not an admission of wrongdoing or an indication that any law was violated.
AstraZeneca will pay $20 million to settle the Plaintiffs' claims in the Settlement. After deducting certain amounts, including amounts approved by the Court for the settlement notice and claims administration, payment of attorneys' fees, reimbursement of Plaintiffs' litigation expenses, and service awards to settlement Class Representatives, the net fund will be distributed in cash to settlement Class members who submit valid claims. If Class members' claims exceed the amount available, payments will be reduced on a proportional basis so that all valid claims can be paid. If there is any money left after paying all valid claims, the excess funds will be distributed as cy pres payments to charities agreed to by the parties and approved by the Court.
Generally, you are a member of the settlement Class if you are a person or entity who, during the period from March 1, 2001, through February 6, 2013: (a) purchased Nexium® in or from Massachusetts, or (b) reimbursed or paid for Nexium® dispensed in Massachusetts, or (c) reimbursed or paid for Nexium® purchased by mail order from Massachusetts.
You are not a member of the settlement Class if you are a government entity (except for government-funded employee benefit funds), you purchased Nexium® for purposes of resale (but solely to the extent of such purchases for purposes of resale), or you are the Judge assigned to this action and any member of the Judge' immediate family.
The settlement Class includes both consumers and entities, known as "Third-Party Payors,"that purchased, reimbursed, or paid for Nexium®.
To qualify for payment from the Settlement, you must timely submit a completed Claim Form. Claim Forms must be postmarked, faxed, sent electronically in PDF format, or submitted online by August 30, 2013.
If you have comments about, or objections to, any aspect of the Settlement, including the requested attorneys' fees or service awards, you may express your views to the Court. Refer to the Full Notice for more information on how to express your views to the Court.
If you do nothing, you will not receive a payment from the Settlement, and you won't be able to start a lawsuit, continue with a lawsuit, or be part of any other lawsuit against AstraZeneca about the legal issues in the Lawsuit.
The Court will hold a Fairness Hearing in Boston, Massachusetts on July 13, 2013. The hearing may be moved to a different date or time, so check this website for updated information.
The Fairness Hearing will determine whether or not the Settlement and the plan for distributing it are fair, adequate, and reasonable, among other things. For complete information on the proposed settlement, to download forms and note important dates and contact information, visit: http://www.massachusettsnexiumlitigation.com
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.Published on Apr-4-13
READ MORE Consumer Fraud Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READER COMMENTS
Diana
on
I would have been better off taking two teaspoons of apple cider vinegar a day until my ph balance got leveled, these nexium ruined me! My God
Marcella Lanehart
on
Veanis Chafin
on
Brenda Gordon
on
Steven
on
Unfortunately your story is not uncommon. I can be of help if you like. Feel free to email me and I will share some info that I have.
Janelle Davis
on
sharlene Ambrose
on
Janna
on
Barbara Bradigan
on
I've been on Nexium for about 10 years now and my doctor has never told me to stop them!! I'm wondering if she even knows?
Are pharmaceutical companies mandated to tell Drs who push their medication, thst something as serious as kidney failure is a possible side effect & that the time taking Nexium should not exceed a certain amount of time?
Isn't the FDA suppose to "protect" us against villainous Pharmaceutical Compamies?
I just heard today on the morning news that Astra Zenica has increased the price of Nexium, over 100%!!!!! Is this because the want to get the most that they can out of it before it's banned? This is ABSOLUTELY CRIMMINAL!
There are such sinister, evil & greedy people at the head of Astra Zeneca,et al. How do they sleep. Innocent people are dying because they trusted their doctor!! But that Dr is in bed with the pharmaceutical companies!
Such a travesty! Shame on them all.
Daniel k Moynihan
on
19 months after my open heart surgery and seven months after my end of proton inhibitors, anti-cholesterol drugs, antiplatelet drugs, 16 mg of Xanax a day . I am on a baby aspirin and take magnesium three times a day to subsidize my level that is now destroyed. My cholesterol is much lower, my energy level is slowly but sure we coming back, I mean slowly. Will never go on your pharmaceutical again!!!
Texas
on